Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Haitao Tang
Observed name:
H. Tang
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
The First Hospital of Changsha
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
The First Hospital of Changsha,
Lu'an First People's Hospital
ORCID:
0009-0003-4547-3012
Observed ORCID:
0009-0003-4547-3012
OpenAlex ID:
A5001045999
The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double‐blind, multicenter study
2024
·
Qianjun Zhuang
, Aijun Liao
, et al.
·
Journal of Gastroenterology and Hepatology
·
37
PDF
Hemithyroidectomy Versus Total Thyroidectomy for Sporadic Medullary Thyroid Cancer: A Chinese Nationwide Large-Scale Cohort Study
2025
·
Xiao Shi
, Cenkai Shen
, et al.
·
Journal of the National Comprehensive Cancer Network
·
28
Updated Thresholds of Basal Calcitonin Level and Extent of Lymph Node Metastasis in Initially Treated Medullary Thyroid Cancer
2025
·
Yuxin Du
, Cenkai Shen
, et al.
·
JAMA Otolaryngology–Head & Neck Surgery
·
19
Thyroid-stimulating hormone suppression in low-risk papillary thyroid cancer: a large-scale retrospective analysis of real-world data
2024
·
Xiao Shi
, Haitao Tang
, et al.
·
EClinicalMedicine
·
12
Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2023
·
Cenkai Shen
, Xiao Shi
, et al.
·
Clinical Cancer Research
·
11
Revised Perspective on the AJCC Staging System for Medullary Thyroid Cancer: A Study of Two Nationwide Cohorts
2025
·
Cenkai Shen
, Yuxin Du
, et al.
·
Journal of the National Comprehensive Cancer Network
·
10
A novel cancer-associated membrane signature predicts prognosis and therapeutic response for lung adenocarcinoma
2025
·
Biao Tu
, Jun Wu
, et al.
·
Scientific Reports
·
4
Decoding Lymph Node Skip Metastasis: Impact on Long-Term Outcomes in Stage T1 Papillary Thyroid Carcinoma
2025
·
Sijia Cai
, Chao Qin
, et al.
·
European Journal of Endocrinology
·
4
Long-term efficacy of lobectomy for stage T1 papillary thyroid carcinoma with varying degrees of lymph node metastasis
2024
·
Chao Qin
, Sijia Cai
, et al.
·
Frontiers in Endocrinology
·
4
Supplementary Methods 1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Data from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Table S2 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Figure S1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
PDF
Figure S1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Figure S2 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Table S2 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Figure S2 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
PDF
Figure S3 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
PDF
Figure S3 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Table S1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Table S1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Data from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Thyroid-Stimulating Hormone Suppression in Low-Risk Papillary Thyroid Cancer: A Large-Scale Real-World Study
2024
·
Xiao Shi
, Haitao Tang
, et al.
·
SSRN Electronic Journal
1063P Comprehensive genomic profiling of leptomeningeal metastases on NSCLC patients through circulating tumor DNA in cerebrospinal fluid
2022
·
Y. Sen
, H. Tang
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
24
Citation count:
128
H-index:
6
I10-index:
6
Year
Topic
Type